AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

IMMUCELL CORP /DE/ Director's Dealing 2022

Sep 12, 2022

34519_dirs_2022-09-12_05a0e9bc-b82e-4744-82d6-f35401ae07cc.zip

Director's Dealing

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IMMUCELL CORP /DE/ (ICCC)
CIK: 0000811641
Period of Report: 2022-09-08

Reporting Person: Tomsche David Scott (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-09-08	Common Stock, $0.10 per value per share	D	306.0000	$7.6800	Acquired	94325.0000	Direct
2022-09-08	Common Stock, $0.10 per value per share	D	329.0000	$7.7100	Acquired	94654.0000	Direct
2022-09-08	Common Stock, $0.10 per value per share	D	5.0000	$7.7200	Acquired	94659.0000	Direct
2022-09-08	Common Stock, $0.10 per value per share	D	5.0000	$7.7000	Acquired	94664.0000	Direct
2022-09-08	Common Stock, $0.10 per value per share	D	260.0000	$7.6900	Acquired	94924.0000	Direct
2022-09-08	Common Stock, $0.10 per value per share	D	1.0000	$7.6200	Acquired	94925.0000	Direct
2022-09-09	Common Stock, $0.10 per value per share	D	647.0000	$7.7600	Acquired	95572.0000	Direct
2022-09-09	Common Stock, $0.10 per value per share	D	33.0000	$7.8000	Acquired	95605.0000	Direct
2022-09-09	Common Stock, $0.10 per value per share	D	20.0000	$7.7000	Acquired	95625.0000	Direct
2022-09-12	Common Stock, $0.10 per value per share	D	606.0000	$7.7500	Acquired	96231.0000	Direct
2022-09-12	Common Stock, $0.10 per value per share	D	195.0000	$7.8000	Acquired	96426.0000	Direct

Footnotes

F1: (1) This figure includes 6,987 shares of common stock held by immediate family members of Dr. Tomsche.